JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8345 PF-562271 HCl

Target: FAK|Pyk2

Summary: FAK/Pyk2 inhibitor

≥26.35 mg/mL
A8362 Arbidol HCl

Summary: Antiviral chemical agent

≥19.85 mg/mL
A8513 Riluzole

Target: Voltage-gated Sodium (NaV) Channels|glutamate release

Summary: Sodium channel protein inhibitor

≥23.4 mg/mL
A8530 Telbivudine

Summary: Reverse Transcriptase inhibitor

insoluble in EtOH; ≥11.85 mg/mL
A8394 CHIR-124

Target: FLT3|GSK-3|Chk|PDGFR

Summary: Chk1 inhibitor,novel and potent

insoluble in H2O; ≥10.5 mg/mL
A8417 Dofetilide
2 Citation

Target: Delayed rectifier outward potassium current (IKr)

Summary: Potassium channel inhibitor

≥21.15 mg/mL
A8549 LY335979 (Zosuquidar 3HCL)
1 Citation

Target: P-glycoprotein (P-gp)

Summary: Pgp (P-glycoprotein) inhibitor

insoluble in EtOH; ≥17.1 mg/mL
A8611 MeBIO

Summary: CDK/Cyclin/ GSK-3/p25/AhR agonist

soluble in DMSO
A8636 RN486

Summary: Btk inhibitor,potent and selective

≥30.35 mg/mL
A8667 AY-NH2

Summary: Selective PAR4 agonist

Soluble in H2O